Author Fred A. Kuglin presents students, academics, researchers, and professionals working in a variety of contexts with an examination of the impact of 2013 Drug Quality and Security Act on
the pharmaceutical supply chain. The author has organized the main body of his text in ten chapters devoted to the journey and expected destination of H.R. 3204, the world of human drug
compounding, the supply chain world and pharmacy compounding, and a wide variety of other related subjects. Fred A. Kuglin is a supply chain management consultant. Annotation ©2015 Ringgold,
Inc., Portland, OR (protoview.com)
